Shareholder Briefcase
E-Mail Alerts
Download Library
News Feeds
(NASDAQ:ISIS) as of 4:08 PM ET on 07/02/02009
Last:
15.83
Change:
$0.49
(3.00%)
Day High:
16.19
Day Low:
15.67
Interactive Chart »
Recent Releases
06/11/09
Isis Pharmaceuticals to Present at Jefferies' 3rd Annual Healthcare Conference
06/09/09
Isis Highlights New Data on Antisense Drugs to Treat Type 2 Diabetes and Obesity at ADA Scientific Sessions
06/05/09
Isis Pharmaceuticals to Present at Needham's 8th Annual Life Sciences Conference
Analyst
Firm
Phone
James Birchenough
Barclays Capital
415-274-5393
Debjit Chattopadhyay
Boenning & Scattergood, Inc.
610-684-5417
Hamed Khorsand
BWS Financial Inc.
818-332-9696
Lucy Lu
Citigroup Global Markets
212-816-1441
Salveen Kochnover
Collins Stewart LLC
212-389-8052
Eric Schmidt
Cowen and Co., LLC
646-562-1345
Alex To
Cross Current Research LLC
609-243-0082
Eun Yang
Jefferies & Company
212-284-2264
Joseph Schwartz
Leerink Swann & Company
617-918-4575
Shiv Kapoor
Morgan Joseph & Co. Inc.
917-238-8207
Mark Monane
Needham & Company
212-705-0346
Edward Tenthoff
Piper Jaffray & Co.
212-284-9403
Carol Werther
Summer Street Research Partners
617-532-6418
Ian Somaiya
Thomas Weisel Partners
212-271-3761
Aaron Reames
Wachovia Capital Markets, LLC
617-603-4219
Contact Us
Kristina Lemonidis
Director, Investor Relations
Telephone: 760-603-2331
E-mail:
info@isisph.com
(3.00%)
